Press release
The Oregon Group to Attend PDAC 2025 in Toronto
Chairman Anthony Milewski and Christian Purefoy will engage in a series of meetings and interviews throughout the event.
"PDAC is always a highlight of the year, and 2025 is set to be especially significant given shifting global dynamics and the rising importance of critical minerals. North American projects will be in the spotlight more than ever," said Anthony Milewski, Chairman of The Oregon Group.
For further information, please contact: info@theoregongroup.com
About The Oregon Group:
The Oregon Group is an investment research company founded by independent capital markets experts. The company is focused on a variety of key investment trends related to commodities, crypto and the energy transition.
https://theoregongroup.com/
https://anthonymilewski.com/
https://blackvulcan.com/
Stay connected with us on social media:
https://x.com/TheOregonGroup
https://uk.linkedin.com/company/the-oregon-group
SOURCE: The Oregon Group
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Oregon Group to Attend PDAC 2025 in Toronto here
News-ID: 3878439 • Views: …
More Releases from The Oregon Group
The Oregon Group and Anthony Milewski Launch New Podcast: Boom, Bust, and BS
London, March 11, 2025 - The Oregon Group, a leader in mining industry news and investment insights, is excited to announce the launch of Boom, Bust, and BS, a new podcast hosted by renowned investor and industry expert Anthony Milewski and former CNN journalist, Christian Purefoy.
Boom, Bust, and BS will dive deep into the cycles that shape markets, whether it's commodities, energy, technology, or global finance.
Through conversations with top…
The Oregon Group founder, Anthony Milewski, to attend Mining Indaba and 121 Mini …
LONDON, January 28, 2025 - The Oregon Group is pleased to announce its attendance at the upcoming Mining Indaba and 121 Mining Conference. Both conferences are being held in Cape Town, South Africa.
Senior partners will participate in a series of meetings with commodity traders, government officials, industry experts, institutional investors and corporations from February 2 - 6, 2025, followed by various site visits in Africa.
Mining Indaba: between February 2 - 6, members…
The Oregon Group to present at Vancouver Investment Conference and attend AME Ro …
LONDON, January 7, 2025 - The Oregon Group is pleased to announce its attendance at the upcoming Vancouver Resource Investment Conference ("VRIC") and the AME Roundup. Both conferences are being held in Vancouver British Columbia.
Senior partners will participate in a series of meetings with financial institutions, industry experts, corporations from January 19 through 23, 2025, followed by various site visits.
VRIC.
On January 19 & 20, members of The Oregon Group team will…
Anthony Milewski joins Fast Company Executive Board
London, United Kingdom, December 6, 2024 - Anthony Milewski, founder of The Oregon Group, has been accepted into the Fast Company Executive Board, an exclusive community of business leaders committed to shaping the future of business through innovation and design.
Anthony Milewski was selected to join this prestigious organization based on his proven expertise in the commodity industry. As a member, Anthony Milewski joins industry-leading peers across technology, marketing, advertising, social…
More Releases for PDAC
Pancreatic Ductal Adenocarcinoma Pipeline 2025: Pioneering Clinical Developments …
Key companies in pancreatic ductal adenocarcinoma market include Cardiff Oncology, XOMA, Alphamab, Cantargia, RenovoRx, Syntrix Biosystems, Eucure Biopharma, Panbela Therapeutics, Jeil Pharmaceutical, Elicio Therapeutics, Cend Therapeutics, Incyte Corporation, I-Mab Biopharma, Medicenna Therapeutics, and Tarveda Therapeutics.
With Pancreatic Ductal Adenocarcinoma (PDAC) reaching epidemic levels globally and contributing to comorbidities such as diabetes, cardiovascular disease, and other cancers, there is an increasing demand for safer and more effective therapies. According to DelveInsight, the…
Pancreatic Ductal Adenocarcinoma (PDAC) Market Detailed Industry Report Analysis …
Introduction
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer, accounting for over 90% of all cases. It is one of the deadliest cancers worldwide, characterized by late diagnosis, aggressive progression, and limited survival rates. Despite advances in oncology, PDAC remains a significant challenge due to its resistance to conventional therapies and high recurrence rates.
The global healthcare industry is now focusing intensively on PDAC through precision medicine, immunotherapy,…
Pancreatic Ductal Adenocarcinoma (PDAC) Pipeline Analysis (2023) Covering Clinic …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 80+ key pharma and biotech companies are working on 80+ pipeline drugs in the Pancreatic Ductal Adenocarcinoma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Pancreatic Ductal Adenocarcinoma Pipeline Insight,…
Pancreatic Ductal Adenocarcinoma (PDAC) Pipeline Analysis (2023) Covering Clinic …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 80+ key pharma and biotech companies are working on 80+ pipeline drugs in the Pancreatic Ductal Adenocarcinoma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Pancreatic Ductal Adenocarcinoma Pipeline Insight,…
Pancreatic Ductal Adenocarcinoma (PDAC) Market to Witness Upsurge in Growth Duri …
As per DelveInsight, the Pancreatic Ductal Adenocarcinoma Market is anticipated to evolve immensely in the coming years owing to the rise in the number of cases of Pancreatic Ductal Adenocarcinoma and the launch of new therapies in the market.
DelveInsight's "Pancreatic Ductal Adenocarcinoma (PDAC) Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Pancreatic Ductal Adenocarcinoma…
EuroGeoSurveys at the PDAC 2021 Virtual Convention
The Prospectors & Developers Association of Canada (PDAC) has wrapped up its first-ever virtual convention that happened between March 8-11, 2021, receiving positive feedback and industry accolades. The annual PDAC Convention is the premier event of the world’s mineral exploration and mining industry that brings together mining executives, geologists, government officials, investors, analysts, and students from around the globe. With over 7,200 members around the world, PDAC’s mission is to…
